Ethos Technologies just became one of 2026's first major tech IPOs, and the insurtech's debut tells a story of survival. The San Francisco-based life insurance platform raised $200 million going public on Nasdaq Thursday, closing at a $1.1 billion valuation - nearly 60% below its 2021 peak. But co-founders Peter Colis and Lingke Wang have something most insurtech rivals don't: profitability, 50% revenue growth, and a path forward while competitors like Policygenius got acquired and Health IQ filed for bankruptcy.
Ethos Technologies became one of the first major tech companies to test the 2026 public markets Thursday, and the insurtech platform's debut is already being watched as a bellwether for this year's IPO cycle. The company raised approximately $200 million selling 10.5 million shares at $19 each on Nasdaq under the ticker symbol "LIFE" - one of the more fitting choices in recent memory.
But the first-day pop never materialized. Ethos closed at $16.85, down 11% from its IPO price, giving the San Francisco-based company a market capitalization of roughly $1.1 billion. That's a steep markdown from the $2.7 billion valuation it commanded when SoftBank Vision Fund 2 led its last private round in July 2021, according to its SEC filings.
Yet co-founders Peter Colis and Lingke Wang have plenty to celebrate. They've built a 10-year-old business that survived an insurtech shakeout while most competitors fell away. "When we launched [the business], there were like eight or nine other life insurtech startups that looked very similar to Ethos, with similar Series A funding," Colis told TechCrunch. "Over time, the vast majority of those startups have pivoted, been acquired at subscale, remain at subscale or gone out of business."
The body count is real. Policygenius, which raised over $250 million from investors including KKR and Norwest Venture Partners, was acquired by PE-backed Zinnia in 2023. Health IQ, a startup that secured more than $200 million from prominent VCs like Andreessen Horowitz, filed for bankruptcy that same year.
Ethos runs a three-sided platform where consumers buy life insurance policies online in 10 minutes without medical exams. The company says over 10,000 independent agents use its software to sell those policies, and carriers like Legal & General America and John Hancock rely on it for underwriting and administrative services. Critically, Ethos itself isn't an insurer - it's a licensed agency earning commissions on sales, a model that proved more durable than competitors who tried to become carriers themselves.
What separated Ethos from the pack was an obsessive focus on profitability as the venture capital markets froze in 2022. The company, which has raised over $400 million in venture capital, could have easily followed rivals into fire sales or bankruptcy. Instead, it cut hard. "Not knowing what the ongoing funding climate would be, we got really serious about ensuring profitability," Colis said.
That financial discipline paid off. Ethos became profitable by mid-2023, according to its IPO documents, and has maintained year-over-year revenue growth above 50% since then. In the nine months ending September 30, 2025, the company generated nearly $278 million in revenue and just under $46.6 million in net income - the kind of numbers that make public market investors pay attention even in a tough IPO environment.
The decision to go public now, despite a valuation haircut, came down to credibility. When asked why Ethos didn't wait for a better market, Colis explained that going public brings "additional trust and credibility" to potential partners and clients. Because many major insurance carriers are over a century old, being publicly traded signals staying power in an industry where longevity matters more than growth-at-all-costs venture math.
The cap table tells the story of Ethos's journey through multiple venture cycles. The largest outside shareholders include Sequoia, Accel, Google's venture arm GV, and SoftBank, as well as General Catalyst and Heroic Ventures. Notably, Sequoia and Accel did not sell shares in the IPO, the company disclosed - a signal that early backers still see upside despite the down-round pricing.
For the broader market, Ethos's debut is being dissected as a test of investor appetite for profitable tech companies in 2026. The muted first-day performance suggests the IPO window remains selective, rewarding sustainable unit economics over hypergrowth stories. But the fact that the deal got done at all - and that a fintech platform with real revenue and profits found buyers - marks a shift from the deep freeze of 2023 and 2024.
Ethos's IPO is less a victory lap than a survival story. In an era when most insurtech startups either got acquired at fire-sale prices or shut down entirely, the company's path to profitability and public markets stands out. The 59% valuation cut from its 2021 peak stings, but it reflects a broader recalibration across tech as markets reward sustainable growth over venture-funded burn rates. For founders watching the 2026 IPO window crack open, the lesson is clear: profitability isn't optional anymore, it's the entry ticket. And for Ethos's blue-chip backers like Sequoia and Accel who held onto their shares, the bet is that a $1.1 billion public company with 50% growth and real profits has more room to run than a $2.7 billion private unicorn burning cash.
